OrthoPediatrics Corp.
$2.7M 849 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Tulsa Dental Products LLC
Tulsa Dental Products LLC reported $2,720,718.37 across General Payments, Research, and Ownership to 122 physicians and teaching hospitals across 122 transactions.
- $2.7M
- All-tracks total
- 122
- Transactions
- 122
- Recipients
- +$69.7K
- General Payments vs PY2023
Tulsa Dental Products LLC reported $2,720,718.37 across all CMS Open Payments tracks (General + Research + Ownership) to 122 physicians and teaching hospitals in Program Year 2024 - ranking #387 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $2,720,718.37, averaging $22.3K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer tulsa-dental-products-llc Tulsa Dental Products LLC
$2.7M · #387/1,925 · 0.0% industry · PY2024
- TOT $2.7M
- RANK #387
- SHARE 0.0%
- TXN 122
- RCP 122
- CAT 3
- GEN $2.7M
- ΔGEN +$69.7K
- TOP1 30.9%
- PY 2024
Volume peers
Nearest volume peer: OrthoPediatrics Corp. ($2.7M)
Tulsa Dental Products LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Tulsa Dental Products LLC's CMS-reported General Payments increased by $69.7K (+2.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: TULSA DENTAL PRODUCTS LLCPY2023: TULSA DENTAL PRODUCTS LLCPY2024: Tulsa Dental Products LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $2,651,011.86
- PY2024
- $2,720,718.37
What the Data Shows for Tulsa Dental Products LLC
In Program Year 2024, Tulsa Dental Products LLC reported $2,720,718.37 in payments to 122 physicians and teaching hospitals across 122 individual transactions, an average of $22.3K per transaction and $22.3K per recipient. That total places Tulsa Dental Products LLC at rank #387 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
"Royalty or License" leads the 3-category general-payment breakdown below at $2.6M (96.3% of General Payments, 116 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Tulsa Dental Products LLC made 3 types of general payments. "Royalty or License" is the largest category at $2.6M, 96.3% of General Payments.
How Tulsa Dental Products LLC divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $2.6M | 116 | 96.3% |
| Consulting Fee | $100.0K | 4 | 3.7% |
| Food and Beverage | $77.18 | 2 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $2,563,780.54 (94.2%) of $2,720,718.37 in this company's General Payments records across 13 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Tulsa Dental Products LLC
The five named recipients with the highest reported General Payments from this company
- 1
Sergio Kuttler
$841,734.10 across 12 reported transactions
- 2
Michael Scianamblo
$803,550.58 across 18 reported transactions
- 3
Nathan Li
$747,559.02 across 4 reported transactions
- 4
Clifford Ruddle
$100,000.00 across 4 reported transactions
- 5
John West
$70,936.84 across 12 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Tulsa Dental Products LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Tulsa Dental Products LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Tulsa Dental Products LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Provisio Medical, Inc.
$2.7M 13 recipients
Compare payment profiles
Johnson & Johnson Health Care Systems Inc.
$2.7M 501 recipients
Compare payment profiles
Nanovis LLC
$2.7M 24 recipients
Compare payment profiles
Janssen Global Services, LLC
$2.8M 1,190 recipients
Compare payment profiles
Cook Medical LLC
$2.8M 10,056 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.